Survival Hope for Melanoma Patients Thanks to New Vaccine | Melanoma Dispatch |

"University of Adelaide researchers have discovered that a new trial vaccine offers the most promising treatment to date for melanoma that has spread, with increased patient survival rates and improved ability to stop or reverse the cancer.

"The vaccine, known as vaccinia melanoma cell lysate (VMCL), was given regularly as a treatment to 54 South Australian patients with advanced, inoperable melanoma over a 10-year period."

Editor's note: The cancer vaccine VMCL is a type of immunotherapy, which means it boosts a patient's own immune system to fight cancer.